Biotech Medics Ne
BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrat… Read more
Market Cap & Net Worth: Biotech Medics Ne (BMCS)
Biotech Medics Ne (PINK:BMCS) has a market capitalization of $2.87 Million ($2.87 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49921 globally and #15239 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biotech Medics Ne's stock price $0.01 by its total outstanding shares 205356178 (205.36 Million).
Biotech Medics Ne Market Cap History: 2015 to 2025
Biotech Medics Ne's market capitalization history from 2015 to 2025. Data shows growth from $184.82K to $2.87 Million (37.51% CAGR).
Biotech Medics Ne Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biotech Medics Ne's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BMCS by Market Capitalization
Companies near Biotech Medics Ne in the global market cap rankings as of March 19, 2026.
Key companies related to Biotech Medics Ne by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Biotech Medics Ne Historical Marketcap From 2015 to 2025
Between 2015 and today, Biotech Medics Ne's market cap moved from $184.82K to $ 2.87 Million, with a yearly change of 37.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.87 Million | -24.32% |
| 2024 | $3.80 Million | -48.47% |
| 2023 | $7.37 Million | +337.80% |
| 2022 | $1.68 Million | -87.94% |
| 2021 | $13.96 Million | +300.00% |
| 2020 | $3.49 Million | +295.35% |
| 2019 | $883.03K | +207.14% |
| 2018 | $287.50K | +40.00% |
| 2017 | $205.36K | +25.00% |
| 2016 | $164.28K | -11.11% |
| 2015 | $184.82K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Biotech Medics Ne was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.87 Million USD |
| MoneyControl | $2.87 Million USD |
| MarketWatch | $2.87 Million USD |
| marketcap.company | $2.87 Million USD |
| Reuters | $2.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.